Back to Search
Start Over
Home treatment of type VI mucopolysaccharidosis (Maroteaux‐Lamy syndrome) an alternative at this time of COVID‐19 pandemic: A case in Peru
- Source :
- Clinical Case Reports, Clinical Case Reports, Vol 8, Iss 12, Pp 3482-3487 (2020)
- Publication Year :
- 2020
- Publisher :
- John Wiley and Sons Inc., 2020.
-
Abstract
- We report a patient with mucopolysaccharidosis type VI, on long‐term enzyme replacement home therapy. Results support the efficacy and safety benefits, with additional advantage of home therapy to minimize the risk of community‐transmitted infections.
- Subjects :
- Pediatrics
medicine.medical_specialty
Medicine (General)
Coronavirus disease 2019 (COVID-19)
Home therapy
Mucopolysaccharidosis
Mucopolysaccharidosis type VI
Case Report
Case Reports
030204 cardiovascular system & hematology
dermatan sulfate
03 medical and health sciences
0302 clinical medicine
R5-920
Pandemic
medicine
glycosaminoglycan
mucopolysaccharidosis type VI
business.industry
galsulfase
Enzyme replacement therapy
General Medicine
medicine.disease
Maroteaux–Lamy syndrome
030220 oncology & carcinogenesis
Medicine
Home treatment
business
enzyme replacement therapy
Subjects
Details
- Language :
- English
- ISSN :
- 20500904
- Volume :
- 8
- Issue :
- 12
- Database :
- OpenAIRE
- Journal :
- Clinical Case Reports
- Accession number :
- edsair.doi.dedup.....56b2e89c7b25b64578472f773fabbf07